Ozturk, V. Et Al. 2011. Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial. CEPHALALGIA , vol.31, no.1 , 25-26.

Ozturk, V., Ertas, M., BAYKAL, B., Sirin, H., & Ozge, A., (2011). Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial. CEPHALALGIA , vol.31, no.1, 25-26.

Ozturk, V. Et Al. "Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial," CEPHALALGIA , vol.31, no.1, 25-26, 2011

Ozturk, V. Et Al. "Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial." CEPHALALGIA , vol.31, no.1, pp.25-26, 2011

Ozturk, V. Et Al. (2011) . "Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial." CEPHALALGIA , vol.31, no.1, pp.25-26.

@article{article, author={V. Ozturk Et Al. }, title={Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial}, journal={CEPHALALGIA}, year=2011, pages={25-26} }